How Cysteine and Selenocysteine Guard Cells Against Aging and Oxidative Damage

Aging is increasingly understood not simply as the accumulation of damage from reactive oxygen species (ROS), but as a progressive loss of redox resilience — the cellular capacity to sense, respond to, and recover from oxidative challenges. This 2025 narrative review synthesizes current knowledge on how two structurally related but functionally distinct thiol-containing amino acids, cysteine and selenocysteine, serve as central pillars of this redox defense system across the lifespan.

Cysteine and selenocysteine share a core amino acid scaffold but differ critically in their chalcogen side chains — sulfur versus selenium. Selenocysteine's selenol group has a far lower pKa (~5.2 vs. ~8.3 for cysteine's thiol), meaning it exists predominantly in its reactive deprotonated form at physiological pH. This makes selenocysteine a superior nucleophile and electrophile, endowing selenoenzymes like GPx and TrxR with catalytic rates that cysteine-containing analogs cannot match. The review details the elaborate translational machinery required to incorporate selenocysteine — involving UGA codon recoding, the SECIS mRNA element, SECIS-binding protein 2 (SBP2), and the dedicated elongation factor eEFSec — underscoring the evolutionary investment cells have made in this amino acid.

Cysteine's roles, while less catalytically potent, are equally indispensable. As the rate-limiting precursor for glutathione synthesis, cysteine availability directly governs intracellular GSH levels. Cysteine residues in proteins also act as dynamic redox switches: reversible oxidation to sulfenic acid (-SOH) modulates signaling, while irreversible over-oxidation to sulfinic or sulfonic acid can inactivate enzymes. Key redox proteins including peroxiredoxins and protein disulfide isomerases rely on these cysteine-based mechanisms. The extracellular cysteine/cystine (Cys/CySS) redox couple is noted as a marker of systemic redox state, separate from and not in thermodynamic equilibrium with the intracellular GSH/GSSG pair.

With aging, mitochondrial dysfunction amplifies ROS production while the capacity to regenerate GSH and maintain selenoprotein expression declines. The review connects this redox imbalance to the onset and progression of neurodegenerative diseases. Supplementation evidence is reviewed: N-acetyl-L-cysteine (NAC) shows neuroprotective effects in aged rodent models; selenocysteine dietary supplementation extends lifespan and increases oxidative stress resistance in C. elegans; and the combined GlyNAC supplement has demonstrated restoration of GSH levels, reduced oxidative stress markers, improved mitochondrial function, and favorable effects on aging biomarkers in older human adults in clinical studies.

The authors frame these findings within the updated redox theory of aging, which distinguishes harmful oxidative damage from physiologically beneficial 'oxidative eustress' — low-level ROS signaling that supports cellular adaptation. Maintaining the proper balance requires adequate supply and regulation of cysteine and selenocysteine throughout life, making these amino acids attractive targets for longevity-focused nutritional and pharmacological strategies.